COVID-19 deaths: Which explanatory variables matter the most?


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2022
Historique:
received: 19 03 2021
accepted: 20 03 2022
entrez: 21 4 2022
pubmed: 22 4 2022
medline: 26 4 2022
Statut: epublish

Résumé

More than a year since the appearance of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), many questions about the disease COVID-19 have been answered; however, many more remain poorly understood. Although the situation continues to evolve, it is crucial to understand what factors may be driving transmission through different populations, both for potential future waves, as well as the implications for future pandemics. In this report, we compiled a database of more than 28 potentially explanatory variables for each of the 50 U.S. states through early May 2020. Using a combination of traditional statistical and modern machine learning approaches, we identified those variables that were the most statistically significant, and, those that were the most important. These variables were chosen to be fiduciaries of a range of possible drivers for COVID-19 deaths in the USA. We found that population-weighted population density (PWPD), some "stay at home" metrics, monthly temperature and precipitation, race/ethnicity, and chronic low-respiratory death rate, were all statistically significant. Of these, PWPD and mobility metrics dominated. This suggests that the biggest impact on COVID-19 deaths was, at least initially, a function of where you lived, and not what you did. However, clearly, increasing social distancing has the net effect of (at least temporarily) reducing the effective PWPD. Our results strongly support the idea that the loosening of "lock-down" orders should be tailored to the local PWPD. In contrast to these variables, while still statistically significant, race/ethnicity, health, and climate effects could only account for a few percent of the variability in deaths. Where associations were anticipated but were not found, we discuss how limitations in the parameters chosen may mask a contribution that might otherwise be present.

Identifiants

pubmed: 35446873
doi: 10.1371/journal.pone.0266330
pii: PONE-D-21-08542
pmc: PMC9022803
doi:

Types de publication

Journal Article Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0266330

Déclaration de conflit d'intérêts

All authors are or were employed at Predictive Science Inc. (PSI), a commercial company, when this research was performed. This does not alter our adherence to PLOS ONE policies on sharing data and materials.

Références

PLoS Comput Biol. 2015 Sep 24;11(9):e1004392
pubmed: 26402446
Sci Adv. 2020 Nov 4;6(45):
pubmed: 33148655
Lancet Infect Dis. 2020 May;20(5):533-534
pubmed: 32087114
Diabetes Metab Syndr. 2020 May - Jun;14(3):247-250
pubmed: 32247212
J Microbiol Immunol Infect. 2020 Jun;53(3):467-472
pubmed: 32299783
PLoS Comput Biol. 2021 Jul 29;17(7):e1009230
pubmed: 34324487
Am J Prev Med. 2020 Jul;59(1):137-139
pubmed: 32430225
Euro Surveill. 2020 May;25(21):
pubmed: 32489179
Nature. 2020 Aug;584(7820):257-261
pubmed: 32512579
Econ Inq. 2021 Jan;59(1):29-52
pubmed: 32836519
J Gen Intern Med. 2020 Oct;35(10):3097-3099
pubmed: 32754782
JAMA. 2020 May 19;323(19):1891-1892
pubmed: 32293639
PLoS Comput Biol. 2013;9(5):e1003064
pubmed: 23696723
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
PLoS Comput Biol. 2019 May 23;15(5):e1007013
pubmed: 31120881
J Rural Health. 2020 Jun;36(3):433-445
pubmed: 32543763
Diabetes Metab Syndr. 2020 Jul - Aug;14(4):655-659
pubmed: 32438328
Lancet Public Health. 2020 May;5(5):e256
pubmed: 32199471
Chaos Solitons Fractals. 2020 Jun;135:109846
pubmed: 32341628
JAMA Netw Open. 2020 Jun 1;3(6):e2011834
pubmed: 32525550
CMAJ. 2020 May 11;192(19):E497-E505
pubmed: 32269018
Nat Med. 2020 Aug;26(8):1205-1211
pubmed: 32546824
Clin Chim Acta. 2020 Sep;508:254-266
pubmed: 32474009
Diabetes Metab Syndr. 2020 Jul - Aug;14(4):303-310
pubmed: 32298981
JAMA. 2020 Jun 23;323(24):2466-2467
pubmed: 32391864
Sci Total Environ. 2020 Jul 15;726:138513
pubmed: 32304942
Front Public Health. 2020 Apr 29;8:152
pubmed: 32411652

Auteurs

Pete Riley (P)

Predictive Science Inc., San Diego, California, United States of America.

Allison Riley (A)

Predictive Science Inc., San Diego, California, United States of America.

James Turtle (J)

Predictive Science Inc., San Diego, California, United States of America.

Michal Ben-Nun (M)

Predictive Science Inc., San Diego, California, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH